![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1433917
½º¸¶Æ® ÆÞ½º¿Á½Ã¹ÌÅÍ : ¼¼°è ½ÃÀå Á¡À¯À² ºÐ¼®, »ê¾÷ µ¿Çâ ¹× Åë°è, ¼ºÀå ¿¹Ãø(2024-2029³â)Global Smart Pulse Oximeters - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029) |
¼¼°èÀÇ ½º¸¶Æ® ÆÞ½º¿Á½Ã¹ÌÅÍ ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 13¾ï 4,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ°í 2029³â±îÁö 17¾ï 9,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖÀ¸¸ç, ¿¹Ãø ±â°£(2024-2029³â) Áß 6.15%ÀÇ CAGR·Î ¼ºÀåÇÕ´Ï´Ù.
½ÅÁ¾ Äڷγª¹ÙÀÌ·¯½º °¨¿°Áõ(COVID-19) ¹ÙÀÌ·¯½º´Â ½º¸¶Æ® ÆÞ½º¿Á½Ã¹ÌÅÍ ½ÃÀå¿¡ Å« ¿µÇâÀ» ¹ÌÄ¡°í ÀÖÀ¸¸ç, COVID-19 ÆÒµ¥¹ÍÀ¸·Î ÀÎÇØ Àú»ê¼ÒÁõ »óŸ¦ ¸ð´ÏÅ͸µÇϱâ À§ÇØ ÆÞ½º¿Á½Ã¹ÌÅÍÀÇ Çʿ伺ÀÌ ³ô¾ÆÁ³½À´Ï´Ù. ÀÔ¿øÀÌ ÇÊ¿äÇÒ Á¤µµ·Î ¾ÆÇÁÁö ¾ÊÀº COVID-19 °¨¿° ȯÀÚÀÇ ÇÕº´Áõ À§ÇèÀ» ³·Ãß±â À§ÇØ ÆÞ½º¿Á½Ã¹ÌÅÍ´Â Áý¿¡¼ µ¿¸Æ »ê¼Òȸ¦ ¸ð´ÏÅ͸µÇϰí Àú»ê¼ÒÇ÷Áõ ¡Èİ¡ ³ªÅ¸³ª¸é ÀÇ»çÀÇ ÁøÂûÀ» ¹Þ´Â µ¥ µµ¿òÀÌ µÇ¾ú½À´Ï´Ù. 2020³â 9¿ù ¹Ì±¹ÈäºÎÇÐȸ ¿¬º¸¿¡ °ÔÀçµÈ 'Áý¿¡¼ COVID-19 °¨¿° ȯÀÚ¸¦ ¸ð´ÏÅ͸µÇϱâ À§ÇÑ ¸Æ¹Ú»ê¼ÒÃøÁ¤±âÀÇ ÀáÀçÀû ÇÔÁ¤°ú ½ÇÁ¦ Áöħ'À̶ó´Â Á¦¸ñÀÇ ¿¬±¸¿¡ µû¸£¸é ÁøÇà ÁßÀÎ Äڷγª¹ÙÀÌ·¯½º °¨¿°Áõ(COVID-19 °¨¿°) ÆÒµ¥¹Í ±â°£ Áß ÀϺΠȯÀÚµéÀº È£Èí°ï¶õÀº ¾øÁö¸¸ ½É°¢ÇÑ Àú»ê¼ÒÇ÷ÁõÀ» º¸ÀÌ´Â °æ¿ì°¡ ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ È¯ÀÚÀÇ ÇÕº´Áõ À§ÇèÀ» ÁÙÀ̱â À§ÇØ Á¦¾ÈµÈ ÇØ°áÃ¥ Áß Çϳª´Â COVID-19 °¨¿° Áø´ÜÀ» ¹Þ¾ÒÀ¸³ª ÀÔ¿øÇÒ Á¤µµ·Î ¾ÆÇÁÁö ¾ÊÀº ȯÀÚ´Â Áý¿¡¼ ÆÞ½º¿Á½Ã¹ÌÅÍ·Î µ¿¸ÆÇ÷ »ê¼Òȸ¦ ¸ð´ÏÅ͸µÇϰí Àú»ê¼ÒÇ÷Áõ ¡Èİ¡ ³ªÅ¸³ª¸é º´¿ø¿¡ ¿Í¼ Ä¡·á¸¦ ¹Þµµ·Ï ÇÏ´Â °ÍÀÔ´Ï´Ù. ÇÏ´Â °ÍÀÔ´Ï´Ù. ¸Æ¹Ú »ê¼Ò ÃøÁ¤Àº »ç¿ëÀÌ °£ÆíÇÏ°í ºñ¿ëÀÌ Àú·ÅÇϱ⠶§¹®¿¡ Ãʱ⠴ܰ迡¼ ¹®Á¦¸¦ ÆÄ¾ÇÇÏ´Â µ¥ ¸Å·ÂÀûÀÎ ¼±ÅÃÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. µû¶ó¼ COVID-19´Â ½º¸¶Æ® ÆÞ½º¿Á½Ã¹ÌÅÍ ½ÃÀå¿¡ Å« ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù.
½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡, ³ëÀÎ Àα¸ Áõ°¡, ÈÞ´ë¿ë ¸ð´ÏÅ͸µ Àåºñ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ½º¸¶Æ® ¸Æ¹Ú »ê¼Ò ³óµµ°è ½ÃÀå È®´ëÀÇ ÁÖ¿ä ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¼¼°èº¸°Ç±â±¸(WHO)ÀÇ 2021³â 7¿ù ÃֽŠÁ¤º¸¿¡ µû¸£¸é °ü»óµ¿¸ÆÁúȯ, ³úÇ÷°üÁúȯ, ·ù¸¶Æ¼½º¼º ½ÉÀåÁúȯ, ¼±Ãµ¼º ½ÉÀåÁúȯ µî ½ÉÇ÷°üÁúȯÀÌ Àü ¼¼°è »ç¸ÁÀÇ ÁÖ¿ä ¿øÀÎÀ¸·Î ²ÅÇû½À´Ï´Ù. ¼ÒÇü ÆÞ½º¿Á½Ã¹ÌÅÍ¿¡ ´ëÇÑ ¼ö¿ä´Â ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ±×¿¡ µû¸¥ »ç¸Á·ü Áõ°¡·Î ÀÎÇØ ÃËÁøµÉ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ÀÌ·Î ÀÎÇØ Á¶»ç ´ë»ó ½ÃÀåÀÌ È®´ëµÇ°í ¿¹Ãø ±â°£ Áß Àü ¼¼°è ½ÃÀå È®´ë°¡ °¡¼Ó鵃 °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. 65¼¼ ÀÌ»óÀº ¸¸¼ºÁúȯ¿¡ °É¸± È®·üÀÌ ³ô´Ù´Â Á¡À» °¨¾ÈÇÒ ¶§, ³ëÀÎ Àα¸´Â Á¶»ç ´ë»ó ½ÃÀå¿¡ Å« ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¼¼°èº¸°Ç±â±¸(WHO)¿¡ µû¸£¸é 2021³â¿¡´Â 2030³â±îÁö Àü ¼¼°è Àα¸ 6¸í Áß 1¸íÀÌ 60¼¼ ÀÌ»óÀÌ µÉ °ÍÀ̶ó°í ÇÕ´Ï´Ù. ¶ÇÇÑ ÀÌ ¿¬·É´ëÀÇ Àα¸´Â 2050³â±îÁö 14¾ï ¸íÀ¸·Î 2020³âÀÇ 10¾ï ¸í¿¡¼ Áõ°¡ÇÒ °ÍÀ̶ó°í º¸°íÇß½À´Ï´Ù. Àü ¼¼°è 60¼¼ ÀÌ»ó Àα¸´Â 2050³â±îÁö µÎ ¹è·Î Áõ°¡Çϸç 21¾ï ¸í¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. 80¼¼ ÀÌ»ó Àα¸´Â 2020³â¿¡¼ 2050³â »çÀÌ¿¡ 3¹è Áõ°¡ÇÏ¿© 4¾ï 2,600¸¸ ¸í¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
¶ÇÇÑ ÁÖ¿ä ½ÃÀå ÁøÃâ±â¾÷Àº Á¦Ç° Ãâ½Ã, Àμö ÇÕº´ ¹× ÆÄÆ®³Ê½ÊÀ» ÅëÇØ ¿¹Ãø ±â°£ Áß ½ÃÀå È®´ë¸¦ Ã¥ÀÓÁú °ÍÀÔ´Ï´Ù. ¿¹¸¦ µé¾î 2021³â 6¿ù¿¡ DetelPro´Â Oxy10 ÆÞ½º¿Á½Ã¹ÌÅ͸¦ Ãâ½ÃÇÒ ¿¹Á¤ÀÔ´Ï´Ù. DetelPro Oxy10 »ç¿ëÀÚ´Â ³»ÀåµÈ LED µð½ºÇ÷¹ÀÌ ´öºÐ¿¡ °á°ú¸¦ Áï½Ã È®ÀÎÇÒ ¼ö ÀÖ½À´Ï´Ù. ¸Æ¹Ú »ê¼Ò ³óµµ°è´Â »ê¼Ò Æ÷ȵµ¿Í ¸Æ¹Ú¼ö¸¦ Ç¥½ÃÇϸç, ¼Õ³¡¿¡ Âø¿ëÇÒ ¼ö ÀÖÀ» Á¤µµ·Î ÀÛ½À´Ï´Ù.
µû¶ó¼ ½º¸¶Æ® ÆÞ½º¿Á½Ã¹ÌÅÍ ½ÃÀåÀº ³ëÀÎ Àα¸ÀÇ ½ÉÇ÷°ü Áúȯ ¹ß»ý·ü Áõ°¡·Î ÀÎÇØ ¿¹Ãø ±â°£ Áß »ó´çÇÑ ¼ö¿ä°¡ ¹ß»ýÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±×·¯³ª ³ôÀº ºñ¿ë°ú Á¦ÇÑµÈ »óȯÀº ½ÃÀå ¼ºÀåÀ» ¹æÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.
¼ÒÇü ¸Æ¹Ú »ê¼Ò ³óµµ°è´Â ¼Õ°¡¶ô, ¹ß°¡¶ô ¶Ç´Â ±ÓºÒ¿¡ ¼¾¼¸¦ ºÎÂøÇÏ°í ºÐ±¤±¤µµ¹ýÀ» »ç¿ëÇÏ¿© ¸ð¼¼Ç÷°ü ³×Æ®¿öÅ©¿¡¼ ¸Æµ¿ÇÏ´Â »ê¼ÒÈ Çì¸ð±Û·ÎºóÀÇ ºñÀ²À» °è»êÇÏ¿© °³ÀÎÀÇ Ç÷¾× »ê¼Ò Æ÷ȵµ¸¦ ÃøÁ¤ÇÏ´Â ºñħ½ÀÀû ÀÇ·á±â±âÀÔ´Ï´Ù. ¼Õ°¡¶ô ¸Æ¹Ú »ê¼ÒÆ÷ȵµ ÃøÁ¤±â´Â ´Ù¾çÇÑ ±â´ÉÀ¸·Î ÀÎÇØ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÇ·á ½Ã½ºÅÛÀº ½ÉÀå ÁúȯÀÇ ¹ß»ý·ü Áõ°¡·Î ÀÎÇØ ºÎ´ãÀ» ¹Þ°í ÀÖ½À´Ï´Ù.
½ÅÁ¦Ç° Ãâ½Ã¿Í FDA ½ÂÀÎÀ¸·Î ÀÎÇØ ¿¹Ãø ±â°£ Áß ½ÃÀåÀÌ È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î 2021³â 1¿ù ŸÀÌÅäÄɾî´Â ¼Õ°¡¶ô ³¡ ¸Æ¹Ú »ê¼Ò ³óµµ°è(SpO2)¸¦ Ãâ½ÃÇß½À´Ï´Ù. ÀÌ ÀÇ·á±â±â¸¦ ÅëÇØ »ç¿ëÀÚ´Â ½É¹Ú¼ö¿Í Ç÷Áß »ê¼Ò Æ÷ȵµ¸¦ ¿ø°ÝÀ¸·Î È®ÀÎÇÒ ¼ö ÀÖ½À´Ï´Ù.
¶ÇÇÑ ±â¼ú ¹ßÀüÀº ÀÌ ½ÃÀå ºÎ¹®ÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î 2021³â 8¿ù ¸¶Æ¼¸ð´Â ¸¶Æ¼¸ð ¾ÈÀü¸Á °æ°íÀÇ CE ¸¶Å©¸¦ ȹµæÇÏ°í ¼À¯·´¿¡¼ Ãâ½ÃÇß½À´Ï´Ù. ÀÌ´Â °¡Á¤¿¡¼ »ç¿ëÇϵµ·Ï ¼³°èµÈ µ¿¸ÆÇ÷ »ê¼Ò Æ÷ȵµ ¸ð´ÏÅ͸µ ¹× °æ°í ½Ã½ºÅÛÀÔ´Ï´Ù. Masimo SafetyNet Alert´Â Signal Extraction Technology ¿þ¾î·¯ºí ¼Õ°¡¶ô ³¡ ¸Æ¹Ú »ê¼ÒÆ÷ȵµ ÃøÁ¤ ¼¾¼¿Í ÇÔ²² Á¦°øµÇ´Â Ȩ ¸ÞµðÄà Çãºê(Home Medical Hub) ¹× ½º¸¶Æ®Æù ¾Û°ú ¹«¼±À¸·Î Åë½ÅÇÏ´Â ½ÅÈ£ ÃßÃâ ±â¼ú(Signal Extraction Technology) ¿þ¾î·¯ºí ¼Õ°¡¶ô ³¡ ¸Æ¹Ú »ê¼ÒÆ÷ȵµ ¼¾¼¸¦ °®Ãß°í ÀÖ½À´Ï´Ù. Masimo SafetyNet Alert´Â Ç÷Áß »ê¼ÒÆ÷ȵµ(SpO2)¿Í ¸Æ¹Ú¼ö(PR)¸¦ ¸ð´ÏÅ͸µÇÕ´Ï´Ù.
µû¶ó¼ ¾Õ¼ ¾ð±ÞÇÑ ¸ðµç ¿äÀÎÀÇ °á°ú·Î ½ÃÀå ºÎ¹®Àº ¿¹Ãø ±â°£ Áß ºü¸£°Ô »ó½ÂÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ºÏ¹Ì´Â ½ÃÀå¿¡¼ Å« ºñÁßÀ» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Áö¿ª¿¡¼ COVID-19 ȯÀÚ ¸ð´ÏÅ͸µÀ» À§ÇÑ ½º¸¶Æ® ÆÞ½º¿Á½Ã¹ÌÅÍ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó COVID-19´Â ½º¸¶Æ® ÆÞ½º¿Á½Ã¹ÌÅÍ ½ÃÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î 'ÆÞ½º¿Á½Ã¹ÌÅ͸¦ »ç¿ëÇÏ¿© Áý¿¡¼ COVID-19 °¨¿° ȯÀÚ¸¦ ¸ð´ÏÅ͸µÇÏ´Â ¹æ¹ý'À̶ó´Â Á¦¸ñÀÇ ¿¬±¸ ³í¹®Àº Äڷγª¹ÙÀÌ·¯½º °¨¿°Áõ(COVID-19)ÀÇ À¯ÇàÀÌ °è¼ÓµÇ´Â °¡¿îµ¥ ¼Ò¼È¹Ìµð¾î¿Í ÀÏ¹Ý ¾ð·Ð º¸µµ¿¡ µû¸£¸é ÀϺΠȯÀÚ°¡ ½É°¢ÇÑ Áõ»óÀ» º¸ÀÌ´Â °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. È£Èí°ï¶õÀ» µ¿¹ÝÇÏÁö ¾Ê´Â Àú»ê¼ÒÁõ, 'ħ¹¬ÀÇ Àú»ê¼ÒÇ÷Áõ'À¸·Î ¾Ë·ÁÁø Áõ»óÀ¸·Î, 2021³â 9¿ù ¹Ì±¹ ÈäºÎÇÐȸ ¿¬·Êº¸°í¼¿¡ "¼Ò¼öÀÇ »ç¶÷µéÀÌ ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ·¯ÇÑ È¯ÀÚÀÇ ÇÕº´Áõ À§ÇèÀ» ÁÙÀ̱â À§ÇÑ ÇÑ °¡Áö Á¦¾ÈÀº ¾ÆÁ÷ ÀÔ¿øÀÌ ÇÊ¿äÇÒ Á¤µµ·Î ½É°¢ÇÏÁö ¾ÊÀº COVID-19 ȯÀÚ´Â Áý¿¡¼ ÆÞ½º¿Á½Ã¹ÌÅ͸¦ »ç¿ëÇÏ¿© µ¿¸Æ »ê¼Òȸ¦ ¸ð´ÏÅ͸µÇϰí Àú»ê¼ÒÇ÷Áõ Áõ»óÀÌ ³ªÅ¸³ª¸é ÀÇ»çÀÇ ÁøÂûÀ» ¹Þµµ·Ï ÇÏ´Â °ÍÀÔ´Ï´Ù.
ÀÇ·á ÀÎÇÁ¶óÀÇ °³¼±°ú ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ Á¸Àç·Î ÀÎÇØ ÀÌ Áö¿ª¿¡´Â »ó´çÇÑ ½º¸¶Æ® ÆÞ½º¿Á½Ã¹ÌÅÍ ½ÃÀåÀÌ Á¸ÀçÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¹Ì±¹ Áúº´¿¹¹æÅëÁ¦¼¾ÅÍ(CDC)ÀÇ 2022³â 7¿ù ÃֽŠÁ¤º¸¿¡ µû¸£¸é ¸Å³â ¾à 805,000¸íÀÇ ¹Ì±¹ÀÎÀÌ ½ÉÀ帶ºñ¸¦ °æÇèÇϰí ÀÖ½À´Ï´Ù. ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ÆÞ½º¿Á½Ã¹ÌÅÍ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµÇ¾î ½ÃÀå¿¡ µµ¿òÀÌ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¶ÇÇÑ ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀεµ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î ¸¶½Ã¸ð´Â 2020³â 9¿ù ¹Ì±¹ ½ÄǰÀǾ౹(FDA)À¸·ÎºÎÅÍ ÀÓ»óÀûÀ¸·Î ÀÔÁõµÈ SET ¸Æ¹Ú »ê¼Ò ÃøÁ¤, È£Èí¼ö(RRp) ¹× ±âŸ Áß¿äÇÑ ¸Å°³ º¯¼ö¸¦ Á¦°øÇÏ´Â °ß°íÇÑ ÇÚµåÇïµå ÀåºñÀÎ Rad-G ¹Ì±¹ »ê¼Ò ³óµµ°è¸¦ ½ÂÀι޾ҽÀ´Ï´Ù. ÇöÀå Á¡°Ë°ú Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µ ¸ðµÎ °¡´ÉÇÕ´Ï´Ù.
µû¶ó¼ Á¶»ç ´ë»ó ½ÃÀåÀº ÁÖ·Î ÁÂ½Ä »ýȰ ½À°ü°ú Áö¿ª ³ëÀÎ Àα¸ Áõ°¡·Î ÀÎÇÑ ½ÉÀ庴 ºÎ´ã Áõ°¡·Î ÀÎÇØ ¿¹Ãø ±â°£ Áß ¼öÀͼº ³ôÀº ¼ºÀåÀ» ÀÌ·ê °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
½º¸¶Æ® ÆÞ½º¿Á½Ã¹ÌÅÍ ½ÃÀåÀº º»ÁúÀûÀ¸·Î ¼¼ºÐȵǾî ÀÖ½À´Ï´Ù. ½ÃÀå Âü¿©ÀÚµéÀº ½ÃÀå¿¡¼ »õ·Ó°í È¿À²ÀûÀÎ Á¦Ç°À» °³¹ßÇϱâ À§ÇØ ¿¬±¸°³¹ß¿¡ ÁýÁßÇϰí ÀÖ½À´Ï´Ù. ½ÃÀå Âü¿©ÀÚ´Â Contec Medical Systems, GE Healthcare, Halma plc, Koninklijke Philips NV, Masimo Corporation, Medtronic plc, Medtronic plc, Nihon Kohden Corporation, Nonin Medical, Inc. Corporation, Smiths Group plc µîÀÌ ÀÖ½À´Ï´Ù.
The Global Smart Pulse Oximeters Market size is estimated at USD 1.34 billion in 2024, and is expected to reach USD 1.79 billion by 2029, growing at a CAGR of 6.15% during the forecast period (2024-2029).
The COVID-19 virus has had a substantial influence on the market for smart pulse oximeters. The need for pulse oximeters rose to monitor the hypoxia during COVID-19. To lower the risk of complications in COVID-19 patients who are not sick enough to require admission, pulse oximeters assisted in monitoring their arterial oxygenation at home and seeking medical attention if they show signs of hypoxemia. According to a study titled "Pulse Oximetry for Monitoring Patients with COVID-19 at Home Potential Pitfalls and Practical Guidance" published in the Annals of The American Thoracic Society in September 2020, During the ongoing coronavirus disease (COVID-19) pandemic, several patients are presenting with severe hypoxemia in the absence of dyspnea. To decrease the risk of complications in such patients, the one proposed solution has been to have those diagnosed with COVID-19 but not sick enough to warrant admission monitor their arterial oxygenation by pulse oximetry at home and present for care when they show evidence of hypoxemia. Though the ease of use and low cost of pulse oximetry makes this an attractive option for identifying problems at an early stage. Therefore, COVID-19 has a driving influence on the market for smart pulse oximeters market.
The increasing prevalence of cardiovascular diseases, the growing geriatric population, and the rising need for portable monitoring devices are the main drivers of the expansion of the market for smart pulse oximeters. The World Health Organization's July 2021 update states that cardiovascular illnesses, which include conditions including coronary heart disease, cerebrovascular disease, rheumatic heart disease, congenital heart disease, and others, are the main cause of mortality worldwide. The demand for small pulse oximeters is anticipated to be driven by the rising prevalence of cardiovascular diseases and the deaths that are linked to them, which will broaden the market under study and accelerate its global expansion throughout the forecast period. Given that those over 65 are more likely to develop chronic diseases, the geriatric population is anticipated to have a substantial impact on the market under study. According to the World Health Organization, 2021, one in six persons on the earth will be 60 or older by 2030. It also reported that by 2050, there will be 1.4 billion persons in this age group, up from 1 billion in 2020. The number of individuals in the world who are 60 or older will double by 2050 to reach 2.1 billion. The number of people 80 and older is projected to triple between 2020 and 2050, reaching 426 million.
Additionally, the major market participants are responsible for the market's expansion during the forecast period by product launches, mergers, and acquisitions, and partnerships. For instance, in June 2021, DetelPro releases the Oxy10 pulse oximeter. Users of the DetelPro Oxy10 can immediately review the outcomes thanks to the LED display that is built-in. The pulse oximeter, which displays both oxygen saturation and pulse rate, is small enough to be attached to a fingertip.
Therefore, the market for smart pulse oximeters is anticipated to have considerable demand over the forecast period due to the rising incidences of cardiovascular disorders among the geriatric population. However, high cost coupled with limited reimbursement is likely to hinder the market growth.
A small pulse oximeter is a non-invasive medical device that measures an individual's blood oxygen saturation by attaching a sensor to a finger, toe, or earlobe and using spectrophotometry to calculate the percentage of oxygenated hemoglobin pulsating through a network of blood capillaries. Due to the devices' numerous capabilities, finger pulse oximeters are anticipated to have the biggest market share. The healthcare system is burdened by the rising incidence of heart disorders.
The market expansion is projected over the forecast period due to new introductions and FDA approval. For instance, in January 2021, Tyto Care introduced its fingertip pulse oximeter (SpO2). This medical equipment allows users to check their heart rate and blood oxygen saturation levels remotely.
Furthermore, the advancement in technology is expected to propel the growth of the market segment. For Instance, in August 2021, Masimo received CE marking for Masimo SafetyNet Alert and launched it in western Europe. It is an arterial blood oxygen saturation monitoring and alert system designed for use at home. Masimo SafetyNet Alert features a Signal Extraction Technology wearable fingertip pulse oximetry sensor that communicates wirelessly to an accompanying Home Medical Hub and smartphone app. Masimo SafetyNet Alert monitors blood oxygen saturation (SpO2) and pulse rate (PR).
Thus, as a result of all the aforementioned factors, the market segment is anticipated to rise rapidly over the forecast period.
The North American region is expected to hold a significant share in the market. Due to the increase in demand for smart pulse oximeters to monitor COVID-19 patients in the region, COVID-19 has had a beneficial effect on the market for smart pulse oximeters. For instance, the research paper titled "Using Pulse Oximetry to Monitor COVID-19 Patients at Home. Reports on social media and in the general press during the ongoing coronavirus illness (COVID-19) pandemic show that a subset of patients is presenting with severe hypoxia without dyspnea, a condition known as "silent hypoxemia," which was published in the Annals of the American Thoracic Society in September 2021 "by a few. One suggestion to lessen the risk of complications in such patients is to have those with COVID-19 who are not yet sick enough to need admission monitor their arterial oxygenation at home using pulse oximetry and seek medical attention if they exhibit symptoms of hypoxemia.
Due to its improved healthcare infrastructure and the presence of significant market players, the region is anticipated to have a sizable market for smart pulse oximeters. According to the Centers for Disease Control and Prevention (CDC), July 2022 update, around 805,000 Americans experience a heart attack each year. The need for pulse oximeters is anticipated to rise as the prevalence of cardiovascular disorders rises, which will help the market.
Additionally, the approval from the regulatory authority is driving the growth of the market. For Instance, in September 2020, Masimo received United States Food and Drug Administration clearance for the Rad-G Pulse Oximeter, a rugged handheld device that provides clinically proven SET pulse oximetry, respiration rate from the pleth (RRp), and other vital parameters for both spot-checking and continuous monitoring.
Therefore, the studied market is anticipated to experience profitable growth throughout the forecast period due to the growing burden of cardiac illnesses, which is primarily caused by a sedentary lifestyle and the expanding geriatric population in the region.
The Smart Pulse Oximeters market is fragmented in nature. The market players are focusing on R&D to develop new and efficient products in the market. Some of the market players are Contec Medical Systems Co., Ltd., GE Healthcare, Halma plc, Koninklijke Philips N.V., Masimo Corporation, Medtronic plc, Nihon Kohden Corporation, Nonin Medical, Inc., Omron Corporation, and Smiths Group plc.